nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—ABCB1—ovarian cancer	0.462	1	CbGaD
Fesoterodine—ABCB1—Topotecan—ovarian cancer	0.0696	0.184	CbGbCtD
Fesoterodine—ABCB1—Vinorelbine—ovarian cancer	0.049	0.13	CbGbCtD
Fesoterodine—CYP2D6—Vinorelbine—ovarian cancer	0.0462	0.122	CbGbCtD
Fesoterodine—CYP3A4—Topotecan—ovarian cancer	0.0417	0.11	CbGbCtD
Fesoterodine—ABCB1—Paclitaxel—ovarian cancer	0.0345	0.0911	CbGbCtD
Fesoterodine—CYP3A4—Vinorelbine—ovarian cancer	0.0294	0.0777	CbGbCtD
Fesoterodine—ABCB1—Docetaxel—ovarian cancer	0.0249	0.0659	CbGbCtD
Fesoterodine—CYP3A4—Paclitaxel—ovarian cancer	0.0206	0.0546	CbGbCtD
Fesoterodine—ABCB1—Doxorubicin—ovarian cancer	0.0186	0.0491	CbGbCtD
Fesoterodine—CYP2D6—Doxorubicin—ovarian cancer	0.0175	0.0463	CbGbCtD
Fesoterodine—CYP3A4—Docetaxel—ovarian cancer	0.0149	0.0395	CbGbCtD
Fesoterodine—CYP3A4—Doxorubicin—ovarian cancer	0.0111	0.0294	CbGbCtD
Fesoterodine—CHRM3—muscle of abdomen—ovarian cancer	0.0028	0.41	CbGeAlD
Fesoterodine—Infestation—Paclitaxel—ovarian cancer	0.000629	0.0041	CcSEcCtD
Fesoterodine—Urticaria—Chlorambucil—ovarian cancer	0.000622	0.00406	CcSEcCtD
Fesoterodine—Chest pain—Vinorelbine—ovarian cancer	0.000622	0.00405	CcSEcCtD
Fesoterodine—Abdominal pain—Chlorambucil—ovarian cancer	0.000619	0.00404	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000618	0.00403	CcSEcCtD
Fesoterodine—Dyspepsia—Topotecan—ovarian cancer	0.000613	0.004	CcSEcCtD
Fesoterodine—Urinary tract infection—Paclitaxel—ovarian cancer	0.000611	0.00398	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.00061	0.00398	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000602	0.00392	CcSEcCtD
Fesoterodine—Fatigue—Topotecan—ovarian cancer	0.000601	0.00392	CcSEcCtD
Fesoterodine—Dyspepsia—Melphalan—ovarian cancer	0.000601	0.00392	CcSEcCtD
Fesoterodine—CHRM5—epithelium—ovarian cancer	0.000596	0.0872	CbGeAlD
Fesoterodine—Constipation—Topotecan—ovarian cancer	0.000596	0.00389	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000595	0.00388	CcSEcCtD
Fesoterodine—Dry eye—Epirubicin—ovarian cancer	0.000594	0.00387	CcSEcCtD
Fesoterodine—Infection—Vinorelbine—ovarian cancer	0.000592	0.00386	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000589	0.00384	CcSEcCtD
Fesoterodine—Fatigue—Melphalan—ovarian cancer	0.000588	0.00384	CcSEcCtD
Fesoterodine—Nervous system disorder—Vinorelbine—ovarian cancer	0.000585	0.00381	CcSEcCtD
Fesoterodine—Angina pectoris—Docetaxel—ovarian cancer	0.000582	0.0038	CcSEcCtD
Fesoterodine—Tachycardia—Vinorelbine—ovarian cancer	0.000582	0.00379	CcSEcCtD
Fesoterodine—Skin disorder—Vinorelbine—ovarian cancer	0.000579	0.00378	CcSEcCtD
Fesoterodine—Hypersensitivity—Chlorambucil—ovarian cancer	0.000577	0.00376	CcSEcCtD
Fesoterodine—Feeling abnormal—Topotecan—ovarian cancer	0.000574	0.00374	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Topotecan—ovarian cancer	0.00057	0.00372	CcSEcCtD
Fesoterodine—Asthenia—Chlorambucil—ovarian cancer	0.000562	0.00366	CcSEcCtD
Fesoterodine—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000557	0.00363	CcSEcCtD
Fesoterodine—Oedema peripheral—Paclitaxel—ovarian cancer	0.000556	0.00363	CcSEcCtD
Fesoterodine—Pruritus—Chlorambucil—ovarian cancer	0.000554	0.00361	CcSEcCtD
Fesoterodine—Urticaria—Topotecan—ovarian cancer	0.000554	0.00361	CcSEcCtD
Fesoterodine—Urethral disorder—Paclitaxel—ovarian cancer	0.000553	0.00361	CcSEcCtD
Fesoterodine—Abdominal pain—Topotecan—ovarian cancer	0.000551	0.00359	CcSEcCtD
Fesoterodine—Dry eye—Doxorubicin—ovarian cancer	0.000549	0.00358	CcSEcCtD
Fesoterodine—Urticaria—Melphalan—ovarian cancer	0.000542	0.00353	CcSEcCtD
Fesoterodine—Diarrhoea—Chlorambucil—ovarian cancer	0.000536	0.00349	CcSEcCtD
Fesoterodine—Infestation—Docetaxel—ovarian cancer	0.000533	0.00347	CcSEcCtD
Fesoterodine—Infestation NOS—Docetaxel—ovarian cancer	0.000533	0.00347	CcSEcCtD
Fesoterodine—Eye disorder—Paclitaxel—ovarian cancer	0.000527	0.00344	CcSEcCtD
Fesoterodine—Cardiac disorder—Paclitaxel—ovarian cancer	0.000524	0.00342	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000515	0.00336	CcSEcCtD
Fesoterodine—Fatigue—Vinorelbine—ovarian cancer	0.000514	0.00335	CcSEcCtD
Fesoterodine—Hypersensitivity—Topotecan—ovarian cancer	0.000513	0.00335	CcSEcCtD
Fesoterodine—Constipation—Vinorelbine—ovarian cancer	0.00051	0.00332	CcSEcCtD
Fesoterodine—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000509	0.00332	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000504	0.00329	CcSEcCtD
Fesoterodine—Hypersensitivity—Melphalan—ovarian cancer	0.000503	0.00328	CcSEcCtD
Fesoterodine—Asthenia—Topotecan—ovarian cancer	0.0005	0.00326	CcSEcCtD
Fesoterodine—Mental disorder—Paclitaxel—ovarian cancer	0.000495	0.00322	CcSEcCtD
Fesoterodine—Pruritus—Topotecan—ovarian cancer	0.000493	0.00321	CcSEcCtD
Fesoterodine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000491	0.0032	CcSEcCtD
Fesoterodine—Asthenia—Melphalan—ovarian cancer	0.00049	0.00319	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000488	0.00318	CcSEcCtD
Fesoterodine—Flatulence—Paclitaxel—ovarian cancer	0.000484	0.00316	CcSEcCtD
Fesoterodine—Pruritus—Melphalan—ovarian cancer	0.000483	0.00315	CcSEcCtD
Fesoterodine—Dysgeusia—Paclitaxel—ovarian cancer	0.000481	0.00314	CcSEcCtD
Fesoterodine—Diarrhoea—Topotecan—ovarian cancer	0.000477	0.00311	CcSEcCtD
Fesoterodine—Back pain—Paclitaxel—ovarian cancer	0.000475	0.0031	CcSEcCtD
Fesoterodine—Urticaria—Vinorelbine—ovarian cancer	0.000474	0.00309	CcSEcCtD
Fesoterodine—Urinary tract disorder—Docetaxel—ovarian cancer	0.000472	0.00308	CcSEcCtD
Fesoterodine—Abdominal pain—Vinorelbine—ovarian cancer	0.000471	0.00307	CcSEcCtD
Fesoterodine—Oedema peripheral—Docetaxel—ovarian cancer	0.000471	0.00307	CcSEcCtD
Fesoterodine—Urethral disorder—Docetaxel—ovarian cancer	0.000469	0.00306	CcSEcCtD
Fesoterodine—Diarrhoea—Melphalan—ovarian cancer	0.000467	0.00304	CcSEcCtD
Fesoterodine—Nausea—Chlorambucil—ovarian cancer	0.000465	0.00303	CcSEcCtD
Fesoterodine—Vision blurred—Paclitaxel—ovarian cancer	0.000463	0.00302	CcSEcCtD
Fesoterodine—Dizziness—Topotecan—ovarian cancer	0.000461	0.003	CcSEcCtD
Fesoterodine—CHRM4—testis—ovarian cancer	0.000457	0.0669	CbGeAlD
Fesoterodine—Face oedema—Epirubicin—ovarian cancer	0.00045	0.00294	CcSEcCtD
Fesoterodine—Angioedema—Paclitaxel—ovarian cancer	0.000449	0.00293	CcSEcCtD
Fesoterodine—Eye disorder—Docetaxel—ovarian cancer	0.000447	0.00292	CcSEcCtD
Fesoterodine—Cardiac disorder—Docetaxel—ovarian cancer	0.000444	0.0029	CcSEcCtD
Fesoterodine—Vertigo—Paclitaxel—ovarian cancer	0.000441	0.00288	CcSEcCtD
Fesoterodine—Rash—Topotecan—ovarian cancer	0.000439	0.00287	CcSEcCtD
Fesoterodine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000439	0.00286	CcSEcCtD
Fesoterodine—Dermatitis—Topotecan—ovarian cancer	0.000439	0.00286	CcSEcCtD
Fesoterodine—Headache—Topotecan—ovarian cancer	0.000437	0.00285	CcSEcCtD
Fesoterodine—Palpitations—Paclitaxel—ovarian cancer	0.000434	0.00283	CcSEcCtD
Fesoterodine—Mediastinal disorder—Docetaxel—ovarian cancer	0.000431	0.00281	CcSEcCtD
Fesoterodine—Rash—Melphalan—ovarian cancer	0.00043	0.00281	CcSEcCtD
Fesoterodine—Dermatitis—Melphalan—ovarian cancer	0.00043	0.0028	CcSEcCtD
Fesoterodine—Cough—Paclitaxel—ovarian cancer	0.000429	0.0028	CcSEcCtD
Fesoterodine—Asthenia—Vinorelbine—ovarian cancer	0.000428	0.00279	CcSEcCtD
Fesoterodine—Dry skin—Epirubicin—ovarian cancer	0.000428	0.00279	CcSEcCtD
Fesoterodine—Abdominal pain upper—Epirubicin—ovarian cancer	0.000426	0.00278	CcSEcCtD
Fesoterodine—Pruritus—Vinorelbine—ovarian cancer	0.000422	0.00275	CcSEcCtD
Fesoterodine—Mental disorder—Docetaxel—ovarian cancer	0.000419	0.00273	CcSEcCtD
Fesoterodine—Chest pain—Paclitaxel—ovarian cancer	0.000418	0.00273	CcSEcCtD
Fesoterodine—Face oedema—Doxorubicin—ovarian cancer	0.000417	0.00272	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000415	0.00271	CcSEcCtD
Fesoterodine—Nausea—Topotecan—ovarian cancer	0.000414	0.0027	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000411	0.00268	CcSEcCtD
Fesoterodine—Dry mouth—Paclitaxel—ovarian cancer	0.000409	0.00267	CcSEcCtD
Fesoterodine—Diarrhoea—Vinorelbine—ovarian cancer	0.000408	0.00266	CcSEcCtD
Fesoterodine—Dysgeusia—Docetaxel—ovarian cancer	0.000408	0.00266	CcSEcCtD
Fesoterodine—Nausea—Melphalan—ovarian cancer	0.000405	0.00264	CcSEcCtD
Fesoterodine—Confusional state—Paclitaxel—ovarian cancer	0.000404	0.00264	CcSEcCtD
Fesoterodine—Back pain—Docetaxel—ovarian cancer	0.000403	0.00263	CcSEcCtD
Fesoterodine—Infection—Paclitaxel—ovarian cancer	0.000398	0.0026	CcSEcCtD
Fesoterodine—Dry skin—Doxorubicin—ovarian cancer	0.000396	0.00258	CcSEcCtD
Fesoterodine—Dizziness—Vinorelbine—ovarian cancer	0.000394	0.00257	CcSEcCtD
Fesoterodine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000394	0.00257	CcSEcCtD
Fesoterodine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000393	0.00256	CcSEcCtD
Fesoterodine—Angina pectoris—Epirubicin—ovarian cancer	0.000393	0.00256	CcSEcCtD
Fesoterodine—Tachycardia—Paclitaxel—ovarian cancer	0.000391	0.00255	CcSEcCtD
Fesoterodine—Skin disorder—Paclitaxel—ovarian cancer	0.00039	0.00254	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000381	0.00248	CcSEcCtD
Fesoterodine—Dysuria—Epirubicin—ovarian cancer	0.000377	0.00246	CcSEcCtD
Fesoterodine—Rash—Vinorelbine—ovarian cancer	0.000376	0.00245	CcSEcCtD
Fesoterodine—Dermatitis—Vinorelbine—ovarian cancer	0.000376	0.00245	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000375	0.00244	CcSEcCtD
Fesoterodine—Headache—Vinorelbine—ovarian cancer	0.000373	0.00244	CcSEcCtD
Fesoterodine—Palpitations—Docetaxel—ovarian cancer	0.000368	0.0024	CcSEcCtD
Fesoterodine—Cough—Docetaxel—ovarian cancer	0.000363	0.00237	CcSEcCtD
Fesoterodine—Angina pectoris—Doxorubicin—ovarian cancer	0.000363	0.00237	CcSEcCtD
Fesoterodine—Insomnia—Paclitaxel—ovarian cancer	0.000363	0.00236	CcSEcCtD
Fesoterodine—Infestation NOS—Epirubicin—ovarian cancer	0.000359	0.00234	CcSEcCtD
Fesoterodine—Infestation—Epirubicin—ovarian cancer	0.000359	0.00234	CcSEcCtD
Fesoterodine—Somnolence—Paclitaxel—ovarian cancer	0.000356	0.00232	CcSEcCtD
Fesoterodine—Chest pain—Docetaxel—ovarian cancer	0.000355	0.00231	CcSEcCtD
Fesoterodine—Nausea—Vinorelbine—ovarian cancer	0.000354	0.00231	CcSEcCtD
Fesoterodine—Dyspepsia—Paclitaxel—ovarian cancer	0.000353	0.0023	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000352	0.0023	CcSEcCtD
Fesoterodine—Urinary tract infection—Epirubicin—ovarian cancer	0.000349	0.00228	CcSEcCtD
Fesoterodine—Dysuria—Doxorubicin—ovarian cancer	0.000349	0.00227	CcSEcCtD
Fesoterodine—Dry mouth—Docetaxel—ovarian cancer	0.000347	0.00226	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000347	0.00226	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000346	0.00226	CcSEcCtD
Fesoterodine—Fatigue—Paclitaxel—ovarian cancer	0.000346	0.00225	CcSEcCtD
Fesoterodine—Constipation—Paclitaxel—ovarian cancer	0.000343	0.00224	CcSEcCtD
Fesoterodine—Confusional state—Docetaxel—ovarian cancer	0.000343	0.00223	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00034	0.00222	CcSEcCtD
Fesoterodine—Infection—Docetaxel—ovarian cancer	0.000338	0.0022	CcSEcCtD
Fesoterodine—Nervous system disorder—Docetaxel—ovarian cancer	0.000333	0.00217	CcSEcCtD
Fesoterodine—Infestation—Doxorubicin—ovarian cancer	0.000333	0.00217	CcSEcCtD
Fesoterodine—Infestation NOS—Doxorubicin—ovarian cancer	0.000333	0.00217	CcSEcCtD
Fesoterodine—Tachycardia—Docetaxel—ovarian cancer	0.000332	0.00216	CcSEcCtD
Fesoterodine—Feeling abnormal—Paclitaxel—ovarian cancer	0.00033	0.00215	CcSEcCtD
Fesoterodine—Skin disorder—Docetaxel—ovarian cancer	0.00033	0.00215	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000328	0.00214	CcSEcCtD
Fesoterodine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000323	0.00211	CcSEcCtD
Fesoterodine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000319	0.00208	CcSEcCtD
Fesoterodine—Urticaria—Paclitaxel—ovarian cancer	0.000319	0.00208	CcSEcCtD
Fesoterodine—Oedema peripheral—Epirubicin—ovarian cancer	0.000318	0.00207	CcSEcCtD
Fesoterodine—Abdominal pain—Paclitaxel—ovarian cancer	0.000317	0.00207	CcSEcCtD
Fesoterodine—Urethral disorder—Epirubicin—ovarian cancer	0.000316	0.00206	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000315	0.00205	CcSEcCtD
Fesoterodine—Insomnia—Docetaxel—ovarian cancer	0.000307	0.002	CcSEcCtD
Fesoterodine—Somnolence—Docetaxel—ovarian cancer	0.000302	0.00197	CcSEcCtD
Fesoterodine—Eye disorder—Epirubicin—ovarian cancer	0.000302	0.00197	CcSEcCtD
Fesoterodine—Cardiac disorder—Epirubicin—ovarian cancer	0.000299	0.00195	CcSEcCtD
Fesoterodine—Dyspepsia—Docetaxel—ovarian cancer	0.000299	0.00195	CcSEcCtD
Fesoterodine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000295	0.00193	CcSEcCtD
Fesoterodine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000295	0.00192	CcSEcCtD
Fesoterodine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000294	0.00192	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000293	0.00191	CcSEcCtD
Fesoterodine—Fatigue—Docetaxel—ovarian cancer	0.000293	0.00191	CcSEcCtD
Fesoterodine—Urethral disorder—Doxorubicin—ovarian cancer	0.000293	0.00191	CcSEcCtD
Fesoterodine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000291	0.0019	CcSEcCtD
Fesoterodine—Constipation—Docetaxel—ovarian cancer	0.000291	0.0019	CcSEcCtD
Fesoterodine—Asthenia—Paclitaxel—ovarian cancer	0.000288	0.00188	CcSEcCtD
Fesoterodine—Pruritus—Paclitaxel—ovarian cancer	0.000284	0.00185	CcSEcCtD
Fesoterodine—Mental disorder—Epirubicin—ovarian cancer	0.000283	0.00184	CcSEcCtD
Fesoterodine—Feeling abnormal—Docetaxel—ovarian cancer	0.00028	0.00183	CcSEcCtD
Fesoterodine—Eye disorder—Doxorubicin—ovarian cancer	0.000279	0.00182	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000278	0.00181	CcSEcCtD
Fesoterodine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000277	0.00181	CcSEcCtD
Fesoterodine—Flatulence—Epirubicin—ovarian cancer	0.000277	0.0018	CcSEcCtD
Fesoterodine—CHRM1—female reproductive system—ovarian cancer	0.000277	0.0405	CbGeAlD
Fesoterodine—Dysgeusia—Epirubicin—ovarian cancer	0.000275	0.00179	CcSEcCtD
Fesoterodine—Diarrhoea—Paclitaxel—ovarian cancer	0.000274	0.00179	CcSEcCtD
Fesoterodine—Back pain—Epirubicin—ovarian cancer	0.000272	0.00177	CcSEcCtD
Fesoterodine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000269	0.00175	CcSEcCtD
Fesoterodine—Abdominal pain—Docetaxel—ovarian cancer	0.000269	0.00175	CcSEcCtD
Fesoterodine—Dizziness—Paclitaxel—ovarian cancer	0.000265	0.00173	CcSEcCtD
Fesoterodine—Vision blurred—Epirubicin—ovarian cancer	0.000265	0.00173	CcSEcCtD
Fesoterodine—Mental disorder—Doxorubicin—ovarian cancer	0.000262	0.00171	CcSEcCtD
Fesoterodine—Flatulence—Doxorubicin—ovarian cancer	0.000256	0.00167	CcSEcCtD
Fesoterodine—Dysgeusia—Doxorubicin—ovarian cancer	0.000255	0.00166	CcSEcCtD
Fesoterodine—Rash—Paclitaxel—ovarian cancer	0.000253	0.00165	CcSEcCtD
Fesoterodine—Dermatitis—Paclitaxel—ovarian cancer	0.000253	0.00165	CcSEcCtD
Fesoterodine—Vertigo—Epirubicin—ovarian cancer	0.000252	0.00165	CcSEcCtD
Fesoterodine—Back pain—Doxorubicin—ovarian cancer	0.000251	0.00164	CcSEcCtD
Fesoterodine—Headache—Paclitaxel—ovarian cancer	0.000251	0.00164	CcSEcCtD
Fesoterodine—Hypersensitivity—Docetaxel—ovarian cancer	0.00025	0.00163	CcSEcCtD
Fesoterodine—Palpitations—Epirubicin—ovarian cancer	0.000248	0.00162	CcSEcCtD
Fesoterodine—CHRM3—female reproductive system—ovarian cancer	0.000248	0.0362	CbGeAlD
Fesoterodine—Cough—Epirubicin—ovarian cancer	0.000245	0.0016	CcSEcCtD
Fesoterodine—Vision blurred—Doxorubicin—ovarian cancer	0.000245	0.0016	CcSEcCtD
Fesoterodine—Asthenia—Docetaxel—ovarian cancer	0.000244	0.00159	CcSEcCtD
Fesoterodine—Pruritus—Docetaxel—ovarian cancer	0.00024	0.00157	CcSEcCtD
Fesoterodine—Chest pain—Epirubicin—ovarian cancer	0.000239	0.00156	CcSEcCtD
Fesoterodine—Nausea—Paclitaxel—ovarian cancer	0.000238	0.00155	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000238	0.00155	CcSEcCtD
Fesoterodine—Dry mouth—Epirubicin—ovarian cancer	0.000234	0.00153	CcSEcCtD
Fesoterodine—Vertigo—Doxorubicin—ovarian cancer	0.000234	0.00152	CcSEcCtD
Fesoterodine—Diarrhoea—Docetaxel—ovarian cancer	0.000233	0.00152	CcSEcCtD
Fesoterodine—Confusional state—Epirubicin—ovarian cancer	0.000231	0.00151	CcSEcCtD
Fesoterodine—Palpitations—Doxorubicin—ovarian cancer	0.00023	0.0015	CcSEcCtD
Fesoterodine—Infection—Epirubicin—ovarian cancer	0.000228	0.00149	CcSEcCtD
Fesoterodine—Cough—Doxorubicin—ovarian cancer	0.000227	0.00148	CcSEcCtD
Fesoterodine—CHRM3—female gonad—ovarian cancer	0.000225	0.033	CbGeAlD
Fesoterodine—Nervous system disorder—Epirubicin—ovarian cancer	0.000225	0.00147	CcSEcCtD
Fesoterodine—Dizziness—Docetaxel—ovarian cancer	0.000225	0.00147	CcSEcCtD
Fesoterodine—Tachycardia—Epirubicin—ovarian cancer	0.000224	0.00146	CcSEcCtD
Fesoterodine—Skin disorder—Epirubicin—ovarian cancer	0.000223	0.00145	CcSEcCtD
Fesoterodine—Chest pain—Doxorubicin—ovarian cancer	0.000221	0.00144	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00022	0.00143	CcSEcCtD
Fesoterodine—Dry mouth—Doxorubicin—ovarian cancer	0.000216	0.00141	CcSEcCtD
Fesoterodine—Rash—Docetaxel—ovarian cancer	0.000214	0.0014	CcSEcCtD
Fesoterodine—Dermatitis—Docetaxel—ovarian cancer	0.000214	0.0014	CcSEcCtD
Fesoterodine—Confusional state—Doxorubicin—ovarian cancer	0.000214	0.00139	CcSEcCtD
Fesoterodine—Headache—Docetaxel—ovarian cancer	0.000213	0.00139	CcSEcCtD
Fesoterodine—Infection—Doxorubicin—ovarian cancer	0.000211	0.00137	CcSEcCtD
Fesoterodine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000208	0.00136	CcSEcCtD
Fesoterodine—Insomnia—Epirubicin—ovarian cancer	0.000207	0.00135	CcSEcCtD
Fesoterodine—Tachycardia—Doxorubicin—ovarian cancer	0.000207	0.00135	CcSEcCtD
Fesoterodine—Skin disorder—Doxorubicin—ovarian cancer	0.000206	0.00134	CcSEcCtD
Fesoterodine—Somnolence—Epirubicin—ovarian cancer	0.000204	0.00133	CcSEcCtD
Fesoterodine—Nausea—Docetaxel—ovarian cancer	0.000202	0.00132	CcSEcCtD
Fesoterodine—Dyspepsia—Epirubicin—ovarian cancer	0.000202	0.00132	CcSEcCtD
Fesoterodine—CHRM3—testis—ovarian cancer	0.0002	0.0292	CbGeAlD
Fesoterodine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000198	0.00129	CcSEcCtD
Fesoterodine—Fatigue—Epirubicin—ovarian cancer	0.000198	0.00129	CcSEcCtD
Fesoterodine—Constipation—Epirubicin—ovarian cancer	0.000196	0.00128	CcSEcCtD
Fesoterodine—Insomnia—Doxorubicin—ovarian cancer	0.000192	0.00125	CcSEcCtD
Fesoterodine—Feeling abnormal—Epirubicin—ovarian cancer	0.000189	0.00123	CcSEcCtD
Fesoterodine—Somnolence—Doxorubicin—ovarian cancer	0.000189	0.00123	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000187	0.00122	CcSEcCtD
Fesoterodine—Dyspepsia—Doxorubicin—ovarian cancer	0.000187	0.00122	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000183	0.00119	CcSEcCtD
Fesoterodine—Fatigue—Doxorubicin—ovarian cancer	0.000183	0.00119	CcSEcCtD
Fesoterodine—Urticaria—Epirubicin—ovarian cancer	0.000182	0.00119	CcSEcCtD
Fesoterodine—Constipation—Doxorubicin—ovarian cancer	0.000181	0.00118	CcSEcCtD
Fesoterodine—Abdominal pain—Epirubicin—ovarian cancer	0.000181	0.00118	CcSEcCtD
Fesoterodine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000175	0.00114	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000173	0.00113	CcSEcCtD
Fesoterodine—Hypersensitivity—Epirubicin—ovarian cancer	0.000169	0.0011	CcSEcCtD
Fesoterodine—Urticaria—Doxorubicin—ovarian cancer	0.000169	0.0011	CcSEcCtD
Fesoterodine—Abdominal pain—Doxorubicin—ovarian cancer	0.000168	0.00109	CcSEcCtD
Fesoterodine—ABCB1—myometrium—ovarian cancer	0.000165	0.0242	CbGeAlD
Fesoterodine—Asthenia—Epirubicin—ovarian cancer	0.000164	0.00107	CcSEcCtD
Fesoterodine—Pruritus—Epirubicin—ovarian cancer	0.000162	0.00106	CcSEcCtD
Fesoterodine—ABCB1—embryo—ovarian cancer	0.000159	0.0232	CbGeAlD
Fesoterodine—Diarrhoea—Epirubicin—ovarian cancer	0.000157	0.00102	CcSEcCtD
Fesoterodine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000156	0.00102	CcSEcCtD
Fesoterodine—Asthenia—Doxorubicin—ovarian cancer	0.000152	0.000992	CcSEcCtD
Fesoterodine—Dizziness—Epirubicin—ovarian cancer	0.000152	0.000988	CcSEcCtD
Fesoterodine—Pruritus—Doxorubicin—ovarian cancer	0.00015	0.000979	CcSEcCtD
Fesoterodine—Diarrhoea—Doxorubicin—ovarian cancer	0.000145	0.000946	CcSEcCtD
Fesoterodine—Rash—Epirubicin—ovarian cancer	0.000145	0.000942	CcSEcCtD
Fesoterodine—Dermatitis—Epirubicin—ovarian cancer	0.000144	0.000942	CcSEcCtD
Fesoterodine—Headache—Epirubicin—ovarian cancer	0.000144	0.000936	CcSEcCtD
Fesoterodine—Dizziness—Doxorubicin—ovarian cancer	0.00014	0.000915	CcSEcCtD
Fesoterodine—Nausea—Epirubicin—ovarian cancer	0.000136	0.000888	CcSEcCtD
Fesoterodine—CYP3A4—female reproductive system—ovarian cancer	0.000136	0.0199	CbGeAlD
Fesoterodine—CYP2D6—female reproductive system—ovarian cancer	0.000134	0.0196	CbGeAlD
Fesoterodine—Rash—Doxorubicin—ovarian cancer	0.000134	0.000872	CcSEcCtD
Fesoterodine—Dermatitis—Doxorubicin—ovarian cancer	0.000134	0.000871	CcSEcCtD
Fesoterodine—Headache—Doxorubicin—ovarian cancer	0.000133	0.000866	CcSEcCtD
Fesoterodine—ABCB1—epithelium—ovarian cancer	0.00013	0.019	CbGeAlD
Fesoterodine—ABCB1—uterine cervix—ovarian cancer	0.000129	0.0188	CbGeAlD
Fesoterodine—Nausea—Doxorubicin—ovarian cancer	0.000126	0.000822	CcSEcCtD
Fesoterodine—ABCB1—decidua—ovarian cancer	0.000122	0.0179	CbGeAlD
Fesoterodine—CYP2D6—female gonad—ovarian cancer	0.000122	0.0178	CbGeAlD
Fesoterodine—ABCB1—endometrium—ovarian cancer	0.000116	0.017	CbGeAlD
Fesoterodine—CYP2D6—testis—ovarian cancer	0.000108	0.0158	CbGeAlD
Fesoterodine—ABCB1—gonad—ovarian cancer	0.000108	0.0158	CbGeAlD
Fesoterodine—ABCB1—uterus—ovarian cancer	0.000107	0.0157	CbGeAlD
Fesoterodine—ABCB1—female reproductive system—ovarian cancer	9.63e-05	0.0141	CbGeAlD
Fesoterodine—ABCB1—bone marrow—ovarian cancer	9.09e-05	0.0133	CbGeAlD
Fesoterodine—ABCB1—female gonad—ovarian cancer	8.76e-05	0.0128	CbGeAlD
Fesoterodine—ABCB1—vagina—ovarian cancer	8.71e-05	0.0127	CbGeAlD
Fesoterodine—ABCB1—testis—ovarian cancer	7.77e-05	0.0114	CbGeAlD
Fesoterodine—ABCB1—lymph node—ovarian cancer	5.63e-05	0.00824	CbGeAlD
